- Home
- SENEA vs BVS Comparison
SENEA vs BVS Comparison
Compare SENEA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- BVS
- Stock Information
- Founded
- SENEA 1949
- BVS 2011
- Country
- SENEA United States
- BVS United States
- Employees
- SENEA N/A
- BVS N/A
- Industry
- SENEA Packaged Foods
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SENEA Consumer Staples
- BVS Health Care
- Exchange
- SENEA Nasdaq
- BVS Nasdaq
- Market Cap
- SENEA 573.0M
- BVS 496.7M
- IPO Year
- SENEA N/A
- BVS 2021
- Fundamental
- Price
- SENEA $88.50
- BVS $6.68
- Analyst Decision
- SENEA
- BVS Strong Buy
- Analyst Count
- SENEA 0
- BVS 4
- Target Price
- SENEA N/A
- BVS $15.00
- AVG Volume (30 Days)
- SENEA 21.3K
- BVS 445.3K
- Earning Date
- SENEA 06-12-2025
- BVS 05-06-2025
- Dividend Yield
- SENEA N/A
- BVS N/A
- EPS Growth
- SENEA 25.61
- BVS N/A
- EPS
- SENEA 5.45
- BVS N/A
- Revenue
- SENEA $1,541,031,000.00
- BVS $567,699,000.00
- Revenue This Year
- SENEA N/A
- BVS N/A
- Revenue Next Year
- SENEA N/A
- BVS $6.09
- P/E Ratio
- SENEA $16.32
- BVS N/A
- Revenue Growth
- SENEA 4.00
- BVS 8.60
- 52 Week Low
- SENEA $51.79
- BVS $4.51
- 52 Week High
- SENEA $92.00
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- SENEA 54.01
- BVS 35.26
- Support Level
- SENEA $84.66
- BVS $6.02
- Resistance Level
- SENEA $91.68
- BVS $7.07
- Average True Range (ATR)
- SENEA 2.51
- BVS 0.39
- MACD
- SENEA 0.15
- BVS -0.02
- Stochastic Oscillator
- SENEA 59.07
- BVS 33.67
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.